Embla Medical hf: Interim Report Q2 2024 ...Middle East

PR Newswire - News
COPENHAGEN, Denmark, July 23, 2024 /PRNewswire/ -- Delivering our highest ever quarterly sales amounting to USD 217 million Organic growth of 6% for Q2 driven strong performance in Prosthetics & Neuro Orthotics and Patient Care EBITDA was USD 47 million and EBITDA margin was 22% for Q2...

Hence then, the article about embla medical hf interim report q2 2024 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Embla Medical hf: Interim Report Q2 2024 )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News